NCT02192424View on ClinicalTrials.gov

Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)

PHASE3CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2020

Study Completion Date

September 30, 2020

Conditions
Type 2 Diabetes
Interventions
DRUG

Metformin alone

DRUG

Metformin + Intermittent Insulin Therapy

Trial Locations (1)

M5G1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Mount Sinai Hospital, Canada

OTHER

NCT02192424 - Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial) | Biotech Hunter | Biotech Hunter